Diabetes During Pregnancy: How It Impacts Your Baby's Oral Health
"Research reveals that maternal diabetes can cause lasting damage to the development of offspring salivary glands."
Diabetes during pregnancy can significantly impact a baby's development, with potential long-term consequences. While much is known about diabetes' effects on various organs, the impact on the developing salivary glands of offspring has been less clear. New research is changing that, revealing how a diabetic environment in the womb can alter the structure and function of a baby's salivary glands.
Salivary glands are essential for oral health and digestion. These glands produce saliva, which is vital for removing bacteria, maintaining pH balance, and breaking down starches. If maternal diabetes impairs salivary gland development, it can lead to a lifetime of oral and digestive health issues for the child.
This article dives into a detailed study on how maternal diabetes affects the submandibular glands (a major salivary gland) in rat offspring. We'll explore the biochemical, histological, and ultrastructural changes observed, translating complex scientific findings into clear, understandable insights for parents and expectant mothers.
Gestational Diabetes Is Increasing
The CDC reports that the percentage of mothers giving birth who were diagnosed with gestational diabetes rose from 6.0% in 2016 to 8.3% in 2021. Rates increased in every maternal age group and rose with age; in 2021, the rate among mothers aged 40 years or older was 15.6%, nearly six times the rate among mothers younger than 20. A separate CDC National Vital Statistics Reports volume examines trends in prepregnancy diabetes among U.S. mothers giving birth from 2016 through 2021, a distinct condition from gestational diabetes. A 2025 study set out to evaluate U.S. gestational diabetes patterns by race and ethnicity from 2016 to 2024, noting that more recent data had not previously been available.
Care Requires Monitoring and Specialized Support
The CDC notes that diabetes during pregnancy can negatively affect the health of pregnant women and their babies, and that high blood sugar around conception in people with type 1 or type 2 diabetes increases the risk of health problems. The 2026 Standards of Care describe the complexity of insulin management in pregnancy and recommend referral to a specialized center offering team-based care. The team may include a maternal-fetal medicine specialist, an endocrinologist or another clinician experienced in diabetes and pregnancy, a registered dietitian nutritionist, and a diabetes care and education specialist. The Lancet review notes that additional fetal monitoring and assessments for diabetic retinopathy and nephropathy can be unavailable in low-resource settings or create financial challenges.
Insulin Changed the Possibility of Pregnancy
A 2021 review, published 100 years after insulin's discovery, describes insulin as having made it possible for women with diabetes to pursue their family-planning goals and ushered in the field of diabetes in pregnancy. It says the following century brought major advances, with clinical focus on preconception planning and maternal glycemic control making successful pregnancy an achievable goal. A historical book traces beliefs about diabetes in pregnancy and the concern that maternal disease could cause congenital malformations and other consequences in unborn children.
How Maternal Diabetes Changes Salivary Gland Development
A study examined the submandibular glands of rat offspring born to diabetic mothers. These offspring were assessed at two and four weeks after birth to identify specific changes. Using quantitative real-time PCR (QRT-PCR), the researchers measured the mRNA levels of various indicators related to gland development, cell growth, and programmed cell death.
- Epidermal Growth Factor (EGF): Reduced, impacting cell growth
- Cytokeratin 5 (CK5): Reduction, affecting epithelial cell progenitors.
- Cytokeratin 7 (CK7) and Aquaporin 5 (AQP5): Reduction, affecting differentiation markers.
- Bcl2: Reduction of this antiapoptotic marker.
- Bax: Increase of this apoptotic marker.
Recent Review Examines Diabetes in Pregnancy
A 2025 review titled “Navigating Diabetes in Pregnancy: Critical Approaches to …” describes the pathophysiology of insulin resistance during pregnancy, adverse outcomes associated with diabetic pregnancies, and current management. The other supplied research snippets concern salivary-gland or liver studies in animal models, including an alloxan-induced diabetes rat study of curcumin nanoformulation in the submandibular salivary gland and a study of moringa oleifera extract in rat parotid glands. Those snippets do not report findings about babies' oral health in human pregnancies.
Evidence Has Important Research Limits
A study of offspring of diabetic rat mothers states that the effects and gene-expression features of markers in salivary glands of adult diabetic models and their offspring warrant further investigation. A separate review covers effects of maternal diabetes in pregnancy on embryonic and fetal health, newborn health, and long-term neurodevelopment, and emphasizes optimal glycemic control to help alleviate complications. The supplied sources do not establish a specific oral-health outcome for human infants, so animal findings should not be treated as proof of such an outcome.
What These Findings Mean for Your Child's Health
This research highlights the critical need for managing diabetes during pregnancy. The study's conclusion emphasizes that maternal diabetes produces degenerative effects on the structure and function of offspring salivary glands. These effects have implications for both oral and digestive health, potentially setting the stage for long-term complications.
GDM Is Common, With Broad Outcomes Under Review
A 2022 literature review defines gestational diabetes mellitus (GDM) as hyperglycemia first recognized during pregnancy and reports that it affects approximately 15% of pregnancies worldwide. A 2026 umbrella review says it systematically summarizes the full spectrum of adverse health outcomes associated with GDM for pregnant women and their children. The supplied snippets do not specify an oral-health outcome for children, so they support the broader context of GDM and maternal-child outcomes rather than a particular dental effect.
Guidelines and Equitable Technology Access
The World Health Organization released its first global guidelines for managing diabetes during pregnancy on November 14, 2025. The announcement estimates that the condition affects about one in six pregnancies, or 21 million women annually, and describes the recommendations as a roadmap intended to help prevent serious complications for women and their children. A 2026 editorial argues that technological advances and advanced monitoring strategies should be accompanied by explicit attention to health equity, so digital tools are accessible to populations at highest risk rather than worsening existing disparities.
Social Determinants Shape Unequal Risks
A 2025 review reports that rates of diabetes in pregnancy—including type 1, type 2, and gestational diabetes—are increasing and that the condition is associated with greater risk of maternal and neonatal complications. It highlights that certain groups are disproportionately affected and examines disparities and the social determinants of health underlying them. The supplied summary does not identify specific groups or quantify the disparities.
Care and Prevention Affect Families
A 2019 article on case reports says previous interventions to lower diabetes risks among pregnant women had been largely ineffective and calls for effective prevention tools to protect maternal and child health. A 2021 case report on pregnancy with type 1 diabetes describes the American Diabetes Association's recommendation for stringent glycemic targets to prevent adverse maternal and fetal outcomes. It specifies self-monitoring of fasting and postprandial blood glucose and an A1C target below 6% without significant hypoglycemia. The supplied snippets do not describe a specific patient's outcome or an effect on a baby's oral health.
Expectant mothers with diabetes should work closely with their healthcare providers to maintain optimal blood sugar control. This proactive approach can minimize the adverse effects on their baby's developing salivary glands and promote better overall health outcomes.
Further research is needed to fully understand the long-term consequences and explore potential interventions. However, these findings provide valuable insights for healthcare professionals and parents, underscoring the importance of early intervention and preventative strategies to safeguard a child's oral and digestive well-being.